A Comprehensive and Preventative Approach to Neurodegenerative Diseases
Abstract
Elham Nourzai
Neurodegenerative diseases, particularly Alzheimer’s disease (AD), pose an unprecedented threat to global healthcare systems and represent a mounting financial burden on modern society. Current projections indicate costs exceeding $2 trillion globally by 2030, with devastating implications for healthcare infrastructure and societal welfare. Leading economists and healthcare experts warn that, if left unchecked, Alzheimer’s will eventually bankrupt our society—a stark reality driven by the exponential growth in cases and the astronomical costs of late-stage care. Despite significant advances in therapeutic research, contemporary approaches remain largely reactive, focusing on late-stage interventions when neurological damage is already extensive and largely irreversible. There is, therefore, a critical and urgent need to revolutionize our approach by shifting towards proactive disease prevention.
This paper presents a comprehensive framework that leverages three key innovations: established and emerging blood-based biomarker technologies, the implementation of AD Prevention Bonds to overcome current reimbursement challenges, aligning economic incentives with preventative care, and groundbreaking insights into molecular pathways— particularly the role of GLP-1 in neuroprotection. Through Zentara’s holistic approach, we demonstrate how early intervention can fundamentally alter disease trajectories whilst simultaneously addressing the economic challenges that currently impede widespread adoption of preventative measures.